1-(5-bromoindolin-1-yl)-2-p-tolylethanone

ID: ALA4857364

Chembl Id: CHEMBL4857364

PubChem CID: 47444494

Max Phase: Preclinical

Molecular Formula: C17H16BrNO

Molecular Weight: 330.23

Molecule Type: Unknown

Names and Identifiers

Canonical SMILES:  Cc1ccc(CC(=O)N2CCc3cc(Br)ccc32)cc1

Standard InChI:  InChI=1S/C17H16BrNO/c1-12-2-4-13(5-3-12)10-17(20)19-9-8-14-11-15(18)6-7-16(14)19/h2-7,11H,8-10H2,1H3

Standard InChI Key:  UKHXQECFGYYNAS-UHFFFAOYSA-N

Alternative Forms

1. Parent:

   

   ALA4857364

   1-(5-Bromo-2,3-dihydroindol-1-yl)-2-(4-methylphenyl)ethanone

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Unknown

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 330.23

Molecular Weight (Monoisotopic): 329.0415

AlogP: 3.89

#Rotatable Bonds: 2

Polar Surface Area: 20.31

Molecular Species: NEUTRAL

HBA: 1

HBD: ┄

#RO5 Violations: ┄

HBA (Lipinski): 2

HBD (Lipinski): ┄

#RO5 Violations (Lipinski): ┄

CX Acidic pKa: ┄

CX Basic pKa: ┄

CX LogP: 4.23

CX LogD: 4.23

Aromatic Rings: 2

Heavy Atoms: 20

QED Weighted: 0.82

Np Likeness Score: -1.39

References

1. Wang SY, Liu X, Meng LW, Li MM, Li YR, Yu GX, Song J, Zhang HY, Chen P, Zhang SY, Hu T..  (2021)  WITHDRAWN: Discovery of indoline derivatives as anticancer agents via inhibition of tubulin polymerization.,  45  [PMID:34022412] [10.1016/j.bmcl.2021.128131]

2. Wang SY, Liu X, Meng LW, Li MM, Li YR, Yu GX, Song J, Zhang HY, Chen P, Zhang SY, Hu T..  (2021)  Discovery of indoline derivatives as anticancer agents via inhibition of tubulin polymerization.,  43  [PMID:33965530] [10.1016/j.bmcl.2021.128095]

Source

Source(1):

• Scientific Literature